| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/20/2000 | EP1036180A2 Circovirus sequences related to piglet weight loss disease (pwd) |
| 09/20/2000 | EP1036179A1 Method for preparing polypeptides with appropriate glycosilation |
| 09/20/2000 | EP1036178A1 Identification of lysolipid receptors involved in inflammatory response |
| 09/20/2000 | EP1036175A1 Human brain derived kcnq2 potassium channel |
| 09/20/2000 | EP1036168A1 Purification and microsequencing of hyaluronidase isozymes |
| 09/20/2000 | EP1036167A2 Nuclear targeting by means of streptococcal protein h |
| 09/20/2000 | EP1036164A1 Chemokine alpha-5 |
| 09/20/2000 | EP1036163A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| 09/20/2000 | EP1036162A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
| 09/20/2000 | EP1036161A1 Chondrocyte-like cells useful for tissue engineering and methods |
| 09/20/2000 | EP1036095A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander |
| 09/20/2000 | EP1036087A1 Secreted proteins and polynucleotides encoding them |
| 09/20/2000 | EP1036086A1 Caspase-14 polypeptides |
| 09/20/2000 | EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/20/2000 | EP1035856A1 Isolated dna encoding human h3 histamine receptor |
| 09/20/2000 | EP0854883A4 Developmentally-regulated endothelial cell locus-1 |
| 09/20/2000 | EP0775211B1 Fumonisin detoxification enzymes |
| 09/20/2000 | EP0764030B1 Composition containing autoantibodies for tumor therapy and prophylaxis |
| 09/20/2000 | EP0672057B1 Analogs of pth |
| 09/20/2000 | EP0600865B1 Xylanase production |
| 09/20/2000 | EP0586549B1 Selecting ligand agonists and antagonists |
| 09/20/2000 | EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/20/2000 | CN1267333A Expression of fructose 1,6-bisphosphate aldolase in transgenic plants |
| 09/20/2000 | CN1267307A Interleukin-18 binding proteins, their preparation and use |
| 09/20/2000 | CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b |
| 09/20/2000 | CN1267223A Carcinostatic agents |
| 09/20/2000 | CN1267201A Chemical cleaning of biological material |
| 09/20/2000 | CN1056617C Melanoma-inhibiting protein |
| 09/19/2000 | US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage |
| 09/19/2000 | US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides |
| 09/19/2000 | US6121317 Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing |
| 09/19/2000 | US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury |
| 09/19/2000 | US6121044 Potent antigen presenting cell composition |
| 09/19/2000 | US6121042 Apparatus and method for simulating in vivo conditions while seeding and culturing three-dimensional tissue constructs |
| 09/19/2000 | US6121041 Use of microorganisms for decellularizing bioprosthetic tissue |
| 09/19/2000 | US6121035 Amino acid sequences; for screening drugs and producing antibodies |
| 09/19/2000 | US6121030 CSAPK-2 protein and uses therefor |
| 09/19/2000 | US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents |
| 09/19/2000 | US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases |
| 09/19/2000 | US6121016 DNA encoding human follicle stimulating hormone receptor, vectors and cells containing such DNA, and methods of use thereof |
| 09/19/2000 | US6121014 Method for producing a plant-optimized nucleic acid coding sequence |
| 09/19/2000 | US6121007 Reaction-based selection for expression of and concentration of catalytic moieties |
| 09/19/2000 | US6121003 Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use |
| 09/19/2000 | US6120995 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 09/19/2000 | US6120765 Purified peptide |
| 09/19/2000 | CA2300475A1 Cre-inducible expression system |
| 09/17/2000 | CA2300782A1 Modified factor viii cdna |
| 09/15/2000 | CA2293945A1 Culturing method for somatic embryos of coniferous trees |
| 09/14/2000 | WO2000053801A1 Intact cell assay for protein tyrosine phosphatases |
| 09/14/2000 | WO2000053795A1 Adipose-derived stem cells and lattices |
| 09/14/2000 | WO2000053786A1 Stable recombinant influenza viruses free of helper viruses |
| 09/14/2000 | WO2000053766A1 Non-spreading pestivirus |
| 09/14/2000 | WO2000053750A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | WO2000053748A2 Casb618 polynucleotides and polypeptides and their use |
| 09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | WO2000053728A2 Method for cultivating cancer cells from human tissue and device for preparing tissue samples |
| 09/14/2000 | WO2000053727A1 Micropropagation, synthetic seeds and germplasm storage of bamboos |
| 09/14/2000 | WO2000053724A2 Compositions and methods for the modification of gene transcription |
| 09/14/2000 | WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases |
| 09/14/2000 | WO2000053631A1 Mammalian cytokines; related reagents and methods |
| 09/14/2000 | WO2000053630A2 COMPOUNDS THAT DISRUPT MAMMALIAN Rad51 ACTIVITY |
| 09/14/2000 | WO2000053628A2 Genes encoding human potassium channel proteins |
| 09/14/2000 | WO2000053232A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | WO2000053211A2 Method of promoting myocyte proliferation and myocardial tissue repair |
| 09/14/2000 | WO2000053005A1 HETEROGENOUS AND HOMOGENEOUS MOUSE VARIANTS LACKING sno GENE |
| 09/14/2000 | WO2000044722A8 Chondrongenesis promotors and indolin-2-one derivatives |
| 09/14/2000 | WO2000038737A3 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase |
| 09/14/2000 | WO2000037685A3 Method of identifying a psychotropic agent using differential gene expression |
| 09/14/2000 | WO2000037609A3 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 09/14/2000 | WO2000037504A3 Human monoclonal antibodies to ctla-4 |
| 09/14/2000 | WO2000032140B1 System and sequential culture media for in vitro fertilization |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | WO2000029586A3 Maize dna ligase i orthologue and uses thereof |
| 09/14/2000 | WO2000028055A3 Hypersensitive response elicitor-induced stress resistance |
| 09/14/2000 | WO2000027883B1 A method of treating tumors using fas-induced apoptosis |
| 09/14/2000 | WO2000026408A3 A system for cell-based screening |
| 09/14/2000 | WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 09/14/2000 | WO2000025812A3 Method for preparing solid phase conjugate vaccines |
| 09/14/2000 | WO2000024893A3 Methods and compositions for the prevention and treatment of anemia |
| 09/14/2000 | WO2000024770A3 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
| 09/14/2000 | WO2000023588B1 G-protein coupled receptors |
| 09/14/2000 | WO2000022129A9 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 09/14/2000 | WO2000022125A9 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 09/14/2000 | WO2000020452A9 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 09/14/2000 | WO2000000624A8 Production of urokinase in plant-based expression systems |
| 09/14/2000 | WO1999062941A9 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 09/14/2000 | CA2367334A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2367067A1 Heterogenous and homogeneous mouse variants lacking sno gene |
| 09/14/2000 | CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases |
| 09/14/2000 | CA2366706A1 Mammalian cytokines; related reagents and methods |
| 09/14/2000 | CA2366479A1 Compositions and methods for the modification of gene transcription |
| 09/14/2000 | CA2366147A1 Casb618 polynucleotides and polypeptides and their use |
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2366101A1 Intact cell assay for protein tyrosine phosphatases |
| 09/14/2000 | CA2366078A1 Adipose-derived stem cells and lattices |
| 09/14/2000 | CA2365813A1 Stable recombinant influenza viruses free of helper viruses |
| 09/14/2000 | CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |